Phase II study of rituximab containing induction chemotherapy (R-high-CHOP followed by CHASER) and high-dose chemotherapy (LEED) supported with auto-PBSCT for previously untreated patients with advanced mantle cell lymphoma(JCOG0406) - Phase II study of rituximab containing induction chemotherapy (R-high-CHOP followed by CHASER) and high-dose chemotherapy (LEED) supported with auto-PBSCT for previously untreated patients with advanced mantle cell lymphoma(JCOG0406)

Japan Clinical Oncology Group(JCOG)0 个研究点目标入组 45 人开始时间: 2008年6月30日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•1) history of glaucoma 2) in-treatment diabetes mellitus with insulin, or uncontrollable diabetes mellitus 3) uncontrollable hypertension 4) treatemnt required coronary disease, myocardiopathy and/or heart failure, and/or in-treatment arrythmia 5) positibe test for HBs antigen 6) positive test for HCV antibody 7)positive test for HIV antibody 8) interstitial pneumonia, pulmonary fibrosis or severe pulmonaly emphysema 9) severe bacterial infection 10) active another neoplasm 11) pregnant woman, or possible pregnant woman, or lactating woman 12) psychological disease or psychological symptom that seems to bedisturbe to participate in clinical trial

发起方

Japan Clinical Oncology Group(JCOG)